Aurealis Therapeutics is a Swiss-Finnish private biopharmaceutical company developing novel three-in-one combination biologic AUP-16 for chronic non-healing wounds and other regenerative diseases. The product is based on Aurealis Pharma technology where genetically engineered lactic acid bacteria act as millions of small bioreactors in the human tissue and produce multiple human therapeutic proteins into target tissue to effectively and safely re-educate the distorted host immune microenvironment to proper state.
View Top Employees from Aurealis Therapeutics AG| Website | http://aurealistherapeutics.com |
| Revenue | $202000 |
| Employees | 1 (1 on RocketReach) |
| Address | Hochbergerstrasse 60C, Basel, Basel-City 4057, CH |
| Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Aurealis Therapeutics AG employee's phone or email?
Aurealis Therapeutics AG Questions
The Aurealis Therapeutics AG annual revenue was $202000 in 2023.
1 people are employed at Aurealis Therapeutics AG.
Aurealis Therapeutics AG is based in Basel, Basel-City.
The NAICS codes for Aurealis Therapeutics AG are [325, 32, 32541, 3254].
The SIC codes for Aurealis Therapeutics AG are [283, 28].
Top Aurealis Therapeutics AG Employees
